Bazinaprine

Bazinaprine

Clinical data
ATC code	None
Identifiers
IUPAC name 3-{[2-(morpholin-4-yl)ethyl]amino}-6-phenylpyridazine-4-carbonitrile
JSmol)	Interactive image
SMILES N#Cc2cc(nnc2NCCN1CCOCC1)c3ccccc3
InChI InChI=1S/C17H19N5O/c18-13-15-12-16(14-4-2-1-3-5-14)20-21-17(15)19-6-7-22-8-10-23-11-9-22/h1-5,12H,6-11H2,(H,19,21) Y Key:KRNDIPHOJLIHRI-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Bazinaprine (SR-95,191) is an experimental drug candidate. It is a monoamine oxidase inhibitor (MAOI) which is believed to be useful for the treatment of depression. The drug strongly inhibits type A monoamine oxidase, but only weakly inhibits type B. The effects of the drug are reversible in vivo, but not in vitro.^[1] In studies, the chemical has been shown to not interact in vivo with other neurotransmitter or drug receptor sites.^[2]

See also

• Reversible inhibitor of MAO-A
  (RIMA)

References